Johnson & Johnson at #ASH23 (Max Gelman for Endpoints News)
J&J and Genmab tout first-line injectable Darzalex for multiple myeloma: #ASH23
SAN DIEGO — J&J and Genmab fleshed out their case Tuesday morning to move their subcutaneous version of the cancer drug Darzalex into earlier lines …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
